Improvements in quality of life of patients with multiple sclerosis receiving alemtuzumab in clinical practice: the LEMVIDA study. - Meca-Lallana JE; Eichau S; Casanova B; Rodríguez EÁ; Pato A; Forner M; Toledo B (Journal of patient-reported outcomes, 2024)